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Objectives: 
• Teach Medical Intensivists what evidence 
based medicine knows about prognostication 
post CNS – event. 
• How can testing help?  
• What can families expect? 
 
Overview: 
• Tools to Use 
• The Neuro-Consult 
• Outcomes of Common Scenarios 
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Life expectancy in COPD
analysis of pipe and cigar smokers (not shown) revealed that 
their mortality risk was similar to that of smokers (RR = 1.0), 
and higher than that of former smokers (RR = 1.1).
Further analyses (not shown) revealed that the effect 
of COPD did not appear to vary by sex, race, or college 
education. That is, there were no signiﬁ cant interactions. But it 
did vary by age, as we hypothesized, with older persons having 
a lower RR than younger persons (results not shown). This 
was true for those with stage 2 and 3 or 4 COPD, and amongst 
current, former, and never smokers, with one exception (it did 
not hold for the former smokers with moderate COPD). We 
comment further on this issue in the discussion.
The last row of Table 3 shows the mortality rate for the 
composite baseline group: female, age 50–59, non-Caucasian, 
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Figure 2 Kaplan–Meier survival curves of all 6,261 participants age 50 and over in NHANES III, stratifi ed by lung function impairment.
Figure 3 Kaplan–Meier survival curves of 1,294 current smokers age 50 and over in NHANES III, stratifi ed by lung function impairment.
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Current smokers 
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college education, no lung disease, never smoker (ﬁ rst model 
only), low pack-years of smoking (models 1–3 only), normal 
weight, and no other medical conditions. As can be seen, 
even “healthy” current smokers, with low pack-years, have 
a baseline mortality rate that is much higher than the never 
smokers (0.0103 vs. 0.0041). By comparison, we note that 
the corresponding annual mortality rates at age 55 for the 
United States female general population28 and the insured 
population (at time of underwriting)31 are 0.0048 and 0.0009, 
respectively. That is, the best group contemplated by the 
models is slightly better than the general population, but does 
not have mortality as low as the recently insured (who have 
additionally demonstrated normal blood work, urinalysis, 
and electrocardiogram).
The RRs from Table 3 can also be used to compute the 
mortality rate for any combination of levels of the covariates 
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Figure 4 Kaplan–Meier survival curves of 2,261 former smokers age 50 and over in NHANES III, stratifi ed by lung function impairment.
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Figure 5 Kaplan–Meier survival curves of 2,706 never smokers age 50 and over in NHANES III, stratifi ed by lung function impairment.
© 2009 Shavelle et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
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Life expectancy and years of life lost in chronic 
obstructive pulmonary disease: Findings 
from the NHANES III Follow-up Study
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Rationale: Previous studies have demonstrated that chronic obstructive pulmonary disease 
(COPD) causes increased mortality in the general population. But life expectancy and the years 
of life lost have ot been reported.
Obj ctives: To quantify mortality, examine how it varies with age, sex, and other risk factors, 
and determine how life expectanc y is affected.
Methods: We constructed mortality models using the Third National Health and Nutrition 
Examination Survey, adjusting for age, sex, race, and major medical conditions. We used these 
to compute life expectancy and the years of life lost.
Measurements and main results: Pulmonary function testing classiﬁ ed patients as having 
Global Initiative on Obstructive Lung Disease (GOLD) stage 0, 1, 2, 3 or 4 COPD or restriction. 
COPD is associated with only a modest reduction in life expectancy for never smokers, but 
with a very large reduction for current and former smokers. At age 65, the reductions in male 
life expectancy for stage 1, stage 2, and stages 3 or 4 disease in current smokers are 0.3 years, 
2.2 years, and 5.8 years. These are in addition to the 3.5 years lost due to smoking. In former 
smokers the reductions are 1.4 years and 5.6 years for stage 2 and stages 3 or 4 disease, and in 
never smokers they are 0.7 and 1.3 years.
Conclusions: Persons with COPD have an increased risk of mortality compared to those who 
do not, with consequent reduction in life expectancy. The effect is most marked in current 
smokers, and this is further reason for smokers to quit.
Keywords: survival, mortality, longevity, COPD
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease where 
airways in the lungs are damaged. It is a major cause of morbidity and mortality in the 
United States and around the world.1–8 In the United States, COPD was responsible 
for over 120,000 deaths in 2004 and is the only cause of death in the top ﬁ ve to have 
been increasing since 1990.9 Prevalence estimates in the United States range from 10 
to 16 million adults, but the condition may be under-diagnosed.10,11 The overall attribut-
able morbidity and mortality from COPD may, therefore, be underestimated.
Risk factors for COPD include genetic factors and environmental exposures. The 
major exposures are tobacco smoke, occupational dusts and chemicals, and pollution.12 
In industrialized nations, tobacco smoke is the biggest risk factor, where up to 50% 
of long-term smokers will develop COPD,13 while in less industrialized nations it is 
exposure to air pollution.14 Conversely, of persons with COPD in the western world, 
roughly 50% have smoking as the underlying etiology.13 Symptoms generally emerge 
after age 40, but can manifest earlier.
Mannino and colleagues4 analyzed data from the First National Health and Nutrition 
Examination Survey (NHANES I), using a modiﬁ ed version of the Global Initiative 
Previous  smokers 
Consciousness, Coma, and Brain Death—2009 
JAMA. 2009;301(11):1172-1174. 
 doi:10.1001/jama.2009.224. 
Tools to Help 
Imaging 
Fever 
Each degree above 37degrees Celsius: 
 
2 x more likely to die or remain in vegetative 
State after 6 months 
Zeiner A. Hyperthermia After Cardic Arrest Is 
Associated With an Unfavorable Neurologic 
Outcome. Archives of internal medicine. 
2001;161:6. 
EEGs 
 
Malignant - 91 % Mortality 
• Burst suppression 
• Complete suppression 
• Low Voltage 
• Seizures 
(intermitent/continuous) 
Benign 54% mortality 
Markers Of Nerve Injury 
Front. Neurol., 26 April 2013  
S-100B 
World J Biol Chem. 2013 February 26; 4(1): 1-12. 
Enolase 
Crit Care Med 2006 Vol. 34, No. 7 
GFA protein 
NS Enolase 
S100b Protein 

Somatosensory evoked potentials 
(SSEP) 
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Spectrum of Consciousness Disorders  
Awareness 
Wakefullness 

Cardiac Arrest 
Cardiopulmonary Resuscitation : History, Current Practice, and 
FutureDirectionJonas A. Cooper, Joel D. Cooper and Joshua M. Cooper. 
Circulation 2006:114:2839-2849 
Survival to Discharge 
Demetrios et al. CMAJ 2011 
(early release)  
CPR 
 
 
BMC Cardiovascular Disorders 2008, 8:35 
Somatosensory evoked 
potentials (SSEP) 
Markers of Death 

Practice Parameter: Prediction of outcome in 
comatose survivors after cardiopulmonary 
resuscitation (an evidence-based review)‏ 
by E.F.M. Wijdicks, A. Hijdra, G. B. Young, C. L. Bassetti, and S. Wiebe 
Neurology 
Volume 67(2):203-210 
July 25, 2006 
©2006 by Lippincott Williams & Wilkins 
Figure. Decision algorithm for use in prognostication of comatose survivors after 
cardiopulmonary resuscitation.  
E.F.M. Wijdicks et al. Neurology 2006;67:203-210 
©2006 by Lippincott Williams & Wilkins 
Hypothermia and sedation may delay recovery 
and make a clinical examination less reliable 
Samaniego EA, et al. Neurocrit Care. 2011 Aug;15(1):113–9.  




Sepsis Encephalopathy 
• “Present in 50%” of “septic patients” 
• Pathology/Autopsy with Ischemic and 
Hemorrhagic lesions 
 
Crit Care Med 2006 Vol. 34, No. 7 



Locked in Syndrome 
Years Percent Alive 
5 84 
10 56 
20 31 
Bruno, Pellas, & Laureys, Yearbook of IC & EM 2008 
Shavelle RM, Strauss DJ, Katz RT (2008). Survival of persons with locked-in 
syndrome: A correction. Archives of Physical Medicine and Rehabilitation, 
89:1005. 


All were non-ambulatory and incontinent-  
Group 1- on- tube feeds 
Group 2- could be feed 
Group 3- mobile 
T he survival status of subjects was determined at
the anchor point of 16 August 2007; allowing
a 12-month period to elapse between the last
discharged subject in the sample (17 August 2006)
and the anchor point. Participant information was
forwarded to the New South Wales Department of
Births, Deaths and M arriages. Requests to four
additional states and territories of Australia occurred
in cases known to have relocated out-of-state after
discharge. Information regarding the cause and date
of death were obtained for deceased subjects.
Analysis
Using L ife Expectancy (LE) tables [23],
a population-based control sample was first con-
structed based on the sex and age of each T BI
subject corresponding to each year the subjects were
enrolled in the study. T he cumulative risk of death
was calculated for the modelled control sample and
compared with actual sample mortality rates.
Furthermore, a sub-analysis of the modelled and
actual LE data examined the impact of sex-adjusted
mortality rates. Descriptive statistics were under-
taken on cause of death data as small category sizes
prevented inferential analysis.
D ifferences between the living and deceased
groups were measured on several demographic and
injury-related variables using independent sample
t-tests or M ann-Whitney U-tests for non-parametric
analyses (SPSS v.15.0). Chi-square analyses were
used to compare between-group differences on
categorical variables. Differences were considered
statistically significant when p 0.05.
T o examine the impact of functional dependency
at rehabilitation discharge, the data from this study
was compared to data previously collected at the
same facility, reported in 2000 [9]. T he 2000 study
evaluated 476 subjects, on average 5.3 years post-
injury. T he earlier sample included all discharges
during the calendar years1986–1996 and was largely
unstratified for level of functional dependency. T he
overlap between studies meant data from 30 subjects
are present in both data sets.
Results
T ime from injury to the anchor-point ranged from
1.7–18.8 years. Survival status was determined on
average 10.5 years post-injury (SD 5 years). From
this sample of 69 subjects, 25 were deceased at the
anchor point, representing 36% of the sample
(Poisson exact 95% CI 0.234–0.535). In contrast,
only 1.9 deaths (2.8%, Poisson exact 95% CI 0.003–
0.103) were expected in an equivalent modelled
sample from the general population. T he absence of
overlap in the 95% confidence interval suggests that
the mortality rates between the two groups were
significantly different. D ifferences between observed
and expected mortality rate yield an SM R¼13.2.
M ean interval from injury to death was 3.6 years
(range 2 months to 12 years). T he greatest mortality
rate was evident during the first 4 years post-injury
(see Figure 1). One death occurred during the
5th post-injury year. A plateau occurred during years
6–9, during which time no deaths took place. Five
late deaths occurred during years 9–12 post-injury.
Approximately half the sample (55%, 38 subjects)
had sustained their injury more than 10 years
prior to the anchor date, of whom 50% (n¼19)
were deceased when followed-up. In comparison,
18 subjects (26% of total sample) had sustained their
injuries 15 years prior to the anchor point, of whom
seven (39%) were deceased.
Differences between surviving and deceased groups
T able I outlines demographic and injury-related
differences between the deceased and living groups.
T he deceased group were significantly older at the
time of injury (t¼ 2.03; p¼0.05), by an average of
7 years, and included proportionally more
males than the living group ( 2¼4.4; p¼0.04).
T he observed ratio of male:female deaths in the
T BI sample was 11.5 : 1. T his contrasts to
a predicted ratio of male: female deaths of 9.5 : 1 in
the equivalent modelled population sample, equat-
ing to a 21% over-representation of male deaths in
the T BI sample. Differences between groups based
on injury type, initial GCS and compensation status
were not statistically significant. Pre-injury variables
such as drug and alcohol abuse, psychiatric illness,
epilepsy and prior head injury may be associated
with increased risk of death, however in this sample
small numbers prevented further analysis.
T he course of rehabilitation differed between
individuals who later died or survived to follow-up
(see T able II). While FIM TM scores were not
different between groups on admission to rehabilita-
tion, by discharge the group who subsequently died
Figure 1. Survival status of predicted and actual sample.
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The survival status of subjects was determined at
the anchor point of 16 August 2007; allowing
a 12-month period to elapse between the last
discharged subject in the sample (17 August 2006)
and th anc or point. Participant information was
forwarded to the New South Wales Department of
Births, Deaths and M arriages. Requests to four
additional states and territories of Australia occurred
in cases known to have relocated out-of-state after
discharge. Inf rmation regarding the cause and date
of death were obtained for deceased subjects.
Analysis
Using Life Expectancy (LE) tables [23],
a population-based control sample was first con-
structed based on the sex and age of each TBI
subject corresponding to each year the subjects were
enrolled in the study. The cumulative risk of death
was c lculated for the modelled control sample and
compared with actual sample mortality rates.
Furthermore, a sub-analysis of the modelle and
actual LE data examined the impact of sex-adjusted
mortality rate . Descriptive statistics were under-
taken on cause of death data as small category sizes
prevented inferential analysis.
Differences between the living and deceased
groups were me sured on several demographic and
injury-related variables using independent sample
t-tests or M ann-Whitney U-tests for non-parametric
analyses (SPSS v.15.0). Chi-square analyses were
used to compare between-group differences on
c tegorical variables. Differences were considered
statistically significant when p 0.05.
To examine the impact of functional depen ency
at rehabilitation discharge, the data from this study
was compared to data previously collected at the
same facility, reported in 2000 [9]. The 2000 study
evaluated 476 subjects, on average 5.3 years post-
injury. The earlier sample included all disch rges
during the calendar years1986–1996 and was largely
unstratified for level of functional dependency. The
overlap between studies meant data from 30 subjects
are present in both data sets.
Results
T ime from injury to the anchor-point ranged from
1.7–18.8 years. Survival status was determined on
average 10.5 years post-injury (SD 5 years). From
this sample of 69 subjects, 25 were deceased at the
anchor point, representing 36% of the sample
(Poisson exact 95% CI 0.234–0.535). In contrast,
only 1.9 deaths (2.8%, Poisson exact 95% CI 0.003–
0.103) were expected in an equivalent modelled
sample from the general population. The absence of
overlap in the 95% confidence interval suggests that
the mortality rates between the two groups were
significantly different. Differences between observed
and expected mortality rate yield an SM R¼13.2.
M ean interval from injury to death was 3.6 years
(range 2 months to 12 years). The greatest mortality
rate was evident during the first 4 years post-injury
(see Figure 1). One death occurred during the
5th post-injury year. A plateau occurred during years
6–9, during which time no deaths took place. Five
late deaths occurred during years 9–12 post-injury.
Approximately half the sample (55%, 38 subjects)
had sustained their injury more than 10 years
prior to the anchor date, of whom 50% (n¼19)
wer deceased when followed-up. In comparison,
18 subjects (26% of total sample) had sustained their
injuries 15 years prior to the anchor point, of whom
seven (39%) were deceased.
Differences between surviving and deceased groups
Table I outlines demographic and injury-related
ifferences between the deceased and living groups.
The deceased group were significantly older at the
time of injury (t¼ 2.03; p¼0.05), by an average of
7 years, and included proportionally more
males than the living group ( 2¼4.4; p¼0.04).
The observed ratio of male:female deaths in the
TBI sample was 11.5 : 1. This contrasts to
a predicted ratio of male: female deaths of 9.5 : 1 in
the equivalent modelled p pulation sample, equat-
ing to a 21% over-representation of male deaths in
the TBI sample. Differences b twe n groups based
on injury type, initial GCS and compensation status
were not statistically significant. Pre-injury variables
such as drug and alcohol abuse, psychiatric illness,
epilepsy and prior head injury may be associated
with increased risk of de th, howeve in this sample
small numbers prevented further analysis.
The course of rehabilitation differed between
individuals who later died or survived to follow-up
(see Table II). While FIM TM scores were not
different between groups on admission to rehabilita-
tion, by discharge the group who subsequently died
Figure 1. Survival status of predicted and actual sample.
Long-term mortality trends in functionally-dependent adults following severe TBI 921
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Brain Injury, November 2008; 22(12): 919–925
Long- ter m mor tali ty trends in functionally-dependent adults
following severe traumatic-brain injur y
IAN J. BAGULEY, M ELISSA T. NOTT, & SHAM ERAN SLEWA-YOUNAN
Brain Injury Rehabilitation Service, Westmead Hospital, Sydney, Australia
(Received 24 June 2008; accepted 3 September 2008)
Abstract
Primary objective: To investigate mortality trends in functionally dependent adults following traumatic brain injury (TBI).
Methods: Data for 966 consecutive admissions to a specialist TBI rehabilitation service were reviewed. Details for 69
subjects who were functionally dependent at rehabilitation discharge were cross-referenced against the State Government
Death Register. The observed mortality rate was compared to an equivalent population sample derived from Australian
Life Tables.
Results: Twenty-fiv subjects (36%) were deceased at an average 10.5 years post-injury (SD 5 years; range 1.7–18.8 years).
The observed numbers of deaths far exceeded the expected population figure (1.9) for the same period (1989–2007)
yielding a standardized mortality rate of 13.2. M ortality trends suggested a bimodal distribution, with more deaths in the
first 5 years post-injury followed by no further deaths until 9 years post-injury.
Conclusions: M ortality in this functionally-dependent group was significantly associated with age, male sex and degree of
disability at discharge. The bimodal distribution of mortality data suggests different contributory mechanisms to early vs.
late mortality in this group.
Keywords: Mortality, life expectancy, brain injury, severe disability
Introduction
Traumatic brain injury (TBI) is a significant cause
of death and long-term disability worldwide. An
estimated 1.4 million people sustain a TBI in the US
per year, of whom 17% require hospital admission
[1]. Approximately 30–35% of patients admitted
with moderate-to-severe TBI die within the first
30 days following the injury [2–4], a rate 5.2-times
that of mild TBI [2], either due to the initial brain
injury or from related trauma [5].
The literature regarding mortality after this first
30 day period presents a more complex picture.
Authors have presented data from mixed TBI
cohorts, combining acute with post-acute samples
and/or mixing inju y severity, age groups, mod of
injury, physic l outcome and so on. Unsurprisingly,
the heterogeneity of these samples produces
variability in the details of research findings.
However, despite the differences in methodologies,
almost all studies have identified that mortality rates
in adult populations following TBI are higher than
that expected in a non-injured, matched sample. By
comparing TBI data to age- and sex-matched popu-
lation samples, standardized mortality rates (SM R)
following TBI have been reported to increase by
a factor between 1.1–4.0 [2, 5–9]. Where reported,
moderate-to-severe TBI produces a reduction in life
expectancy of 3–9 years [5, 9, 10].
A common, but not universal, pattern to emerge
from these papers is a tendency for the greatest
proportion of deaths to occur in the early years post-
discharge [2, 6, 9, 11]. Others report no such
tendency for deaths to cluster in the years immedi-
ately following discharge [7]. Furthermore, the
Correspondence: Dr Ian J. Baguley, Research Team Leader, Brain Injury Rehabilitation Service, PO Box 533, Wentworthville, NSW 2145, Australia.
Tel: 61-2 98457941. Fax: 61-2 96358892. E-mail: ianb@biru.wsahs.nsw.gov.au
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Prognosis after One Month Of 
Persistent Vegetative State 
   Glasgow Outcome Scale TBI Non-TBI 
Death 1 33 53 
Persistent 
Vegetative State 
2 15 32 
Severe Disability 3 28 11 
Moderate Disability 4 17 3 
Good Recovery 5 7 1 
Outcomes of Vegetative State 
Ledoux et al, Belgian Federal Project on Vegatative State 
doi:10.1016/j.jemermed.2010.04.021
Original
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PROGNOSIS IN PATIENTS PRESENTING WITH NON-TRAUMATIC COMA
Sune Forsberg, MD,*† Jonas Höjer, MD, PHD,†‡ and Ulf Ludwigs, MD, PHD†§
*Medical Intensive Care Unit, South Hospital, Stockholm, Sweden, †Karolinska Institutet, Department of Clinical Science and
Education, Södersjukhuset, Stockholm, Sweden, ‡Swedish Poisons Information Centre, Stockholm, Sweden, and §Department of
Emergency Medicine, Karolinska University Hospital, Solna, Stockholm, Sweden
Reprint Address: Sune Forsberg, MIVA, Karolinska Institute, Södersjukhuset, SE-118 83 Stockholm, Sweden
e Abstract—Background: Studies of patients presenting
with coma are limited, and little is known about the
prognosis of these cases. Objective: The aim of this study
was to investigate the acute and long-term prognosis
after an episode of non-traumatic coma. Methods: Adults
admitted consecutively to an emergency department in
Stockholm, Sweden between February 2003 and May
2005 with a Glasgow Coma Scale (GCS) score of 10 or
below were enrolled prospectively. All available data
were used to explore the cause of the impaired conscious-
ness on admission. Patients surviving hospitalization
were followed-up for 2 years regarding survival. Results:
The ﬁnal study population of 865 patients had the fol-
lowing eight different coma etiologies: poisoning (n
329), stroke (n 213), epilepsy (n 113), circulatory
failure (n 60), infection (n 56), metabolic disorder
(n 44), respiratory insufﬁciency (n 33), and intra-
cranial malignancy (n 17). The hospital mortality rate
among the 865 patients was 26.5%, varying from 0.9%
for epilepsy to 71.7% for circulatory failure. The accu-
mulated total 2-year mortality rate was 43.0%, varying
from 13.7% for poisoning to 88.2% for malignancy. The
level of consciousness on admission also inﬂuenced the
prognosis: a GCS score of 3–6 was associated with a
signiﬁcantly higher hospital mortality rate than a GCS
score of 7–10. Conclusion: The prognosis in patients
presenting with non-traumatic coma is serious and depends
largely on both the level of consciousness on admission and the
etiology of the coma. Adding the suspected coma etiology to
the routine coma grading of these emergencies may more
accurately predict their prognosis. © 2012 Elsevier Inc.
e Keywords—coma; emergency medicine; mortality; progno-
sis; unconsciousness
INTRODUCTION
Approximately 1% of patients admitted to the emer-
gency department (ED) have impaired consciousness
and constitute a high-risk group (1–4). It was recently
reported that hospital mortality was 2.8% in the poi-
soning group and 39% in the group with other diag-
nosis underlying the reduced level of consciousness on
admission to the ED (4). In the management of pa-
tients presenting with coma, several etiologies with
different prognoses have to be considered; for exam-
ple, poisoning, metabolic disorders, acute manifesta-
tions of cerebrovascular disease, epilepsy, circulatory
shock, respiratory failure, and severe infection. The
acute and long-term prognoses in patients with these
different conditions are of great importance for triage
and treatment decisions. The number of published
studies of patients presenting with coma has been
surprisingly small. We have found only three reports
on studies in which the clinical courses of patients admit-
ted unresponsive to the ED have been followed-up (2–4). In
one of these studies, patients with various kinds of
changes in their mental status were included, and in
another one, poisoning was an exclusion criterion
(2,3). In addition, Sacco et al. investigated comatose
intensive care patients and reported on their short-term
Received: 7 October 2009; FINAL SUBMISSION RECEIVED: 5 January 2010;
ACCEPTED: 11 April 2010
The Journal of Emergency Medicine, Vol. 42, No. 3, pp. 249–253, 2012
Copyright © 2012 Elsevier Inc.
Printed in the USA. All rights reserved
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e Abstract—Background: Studies of patients presenting
with coma are limited, and little is known about the
prognosis of these cases. Objective: The aim of this study
was to investigate the acute and long-term prognosis
after an episode of non-traumatic coma. Methods: Adults
admitted consecutively to an emergency department in
Stockholm, Sweden between February 2003 and May
2005 with a Glasgow Coma Scale (GCS) score of 10 or
below were enrolled prospectively. All available data
were used to explore the cause of the impaired conscious-
ness on admission. Patients surviving hospitalization
were followed-up for 2 years regarding survival. Results:
The ﬁnal study population of 865 patients had the fol-
lowing eight different coma etiologies: poisoning (n
329), stroke (n 213), epilepsy (n 113), circulatory
failure (n 60), infection (n 56), metabolic disorder
(n 44), respiratory insufﬁciency (n 33), and intra-
cranial malignancy (n 17). The hospital mortality rate
among the 865 patients was 26.5%, varying from 0.9%
for epilepsy to 71.7% for circulatory failure. The accu-
mulated total 2-year mortality rate was 43.0%, varying
from 13.7% for poisoning to 88.2% for malignancy. The
level of consciousness on admission also inﬂuenced the
prognosis: a GCS score of 3–6 was associated with a
signiﬁcantly higher hospital mortality rate than a GCS
score of 7–10. Conclusion: The prognosis in patients
presenting with non-traumatic coma is serious and depends
largely on both the level of consciousness on admission and the
etiology of the coma. Adding the suspected coma etiology to
the routine coma grading of these emergencies may more
accurately predict their prognosis. © 2012 Elsevier Inc.
e Keywords—coma; emergency medicine; mortality; progno-
sis; unconsciousness
INTRODUCTION
Approximately 1% of patients admitted to the emer-
gency department (ED) have impaired consciousness
and constitute a high-risk group (1– 4). It was recently
reported that hospital mortality was 2.8% in the poi-
soning group and 39% in the group with other diag-
nosis underlying the reduced level of consciousness on
admission to the ED (4). In the management of pa-
tients presenting with coma, several etiologies with
different prognoses have to be considered; for exam-
ple, poisoning, metabolic disorders, acute manifesta-
tions of cerebrovascular disease, epilepsy, circulatory
shock, respiratory failure, and severe infection. The
acute and long-term prognoses in patients with these
different conditions are of great importance for triage
and treatment decisions. The number of published
studies of patients presenting with coma has been
surprisingly small. We have found only three reports
on studies in which the clinical courses of patients admit-
ted unresponsive to the ED have been followed-up (2– 4). In
one of these studies, patients with various kinds of
changes in their mental status were included, and in
another one, poisoning was an exclusion criterion
(2,3). In addition, Sacco et al. investigated comatose
intensive care patients and reported on their short-term
Received: 7 October 2009; FINAL SUBMISSION RECEIVED: 5 January 2010;
ACCEPTED: 11 April 2010
The Journal of Emergency Medicine, Vol. 42, No. 3, pp. 249 –253, 2012
Copyright © 2012 Elsevier Inc.
Printed in the USA. All rights reserved
0736-4679/$–see front matter
249

MCA Stroke: ages 18- 60 
 The Lancet: Neurology, Volume 6, Issue 3, March 2007, Pages 215–222 
Sub-Arachnoid Hemorrhage 

Neuro Radiation for Treatment 
An estimated 20%–40% of cancer patients will 
develop brain metastases. Whole-brain 
radiotherapy (WBRT) is the standard treatment 
for patients with brain metastases. Although 
WBRT can reduce neurologic symptoms, the 
median survival following WBRT is between 
3 and 6 months. 
QUALITY OF LIFE IN BRAIN METASTASES RADIATION TRIALS  
CURRENT ONCOLOGY—VOLUME 15, NUMBER 5 
Function Post XRT for Mets 
Total Dependence 
Clinical Oncology (2001)13:91–94 
Function Post XRT for Mets 
Clinical Oncology (2001)13:91–94 
Good Outcome:  modified Renkin Score 0-2 
Poor Outcome:  modified Renkin Score 3-6 

Clinical examination for outcome prediction in 
nontraumatic coma. 




My Emails 
Mike;  
• Sorry for my late response I have added some info for 
your talk. In terms of prognosis, it depends on the type 
of brain injury. It is very hard to predict. What we can 
effectively do is predict who is gonna do poorly. We 
can’t accurately   predict who is gonna recover or do 
better than PVS, thats the bottom line.  
 
• Most prediction is based on disease specific grading 
systems, usually mortality. Prediction of disability is 
expert based, very hard to do. Most research is after 
Cardiac Arrest. 
 
Risk For Delerium 
Older age (more than 70 years),  
Male gender, 
Poor functional status,  
Malnutrition,  
Substance abuse 
Pre-morbid medical conditions or cognitive impairment 
Polypharmacy, including medications that affect neurotransmitters (such as 
 anticholinergic or dopaminergic) 
Physical restraints 
Visual or hearing impairment 
Prior history of delirium  
 
Katramados A, Varelas P. Encephalopathy. In: 
Torbey M, ed. Neurocritical Care: Cambridge 
University Press; 2010:220-6. 
Days of Delerium with  Mortality in 
ICU pts over  60 y.o. 
Pisani et al. American Journal of Respiratory and 
Critical Care Medicine Vol 180. pp. 1092-1097, (2009) 
Quality Of Life- SF 36 

The Brain Post ICU 
Arch Intern Med. 2007;167(12):1312-1320.  
 
This is your brain on Drugs 
This is your brain after MICU 
Any Questions? 
